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On the basis of formerly investigated peptides corresponding to
the endotoxin-binding domain from LALF [Limulus anti-LPS
(lipopolysaccharide) factor], a protein from Limulus polyphemus,
we have designed and synthesized peptides of different lengths
with the aim of obtaining potential therapeutic agents against
septic shock syndrome. For an understanding of the mechanisms
of action, we performed a detailed physicochemical and biophy-
sical analysis of the interaction of rough mutant LPS with
these peptides by applying FTIR (Fourier-transform infrared)
spectroscopy, SAXS (small-angle X-ray scattering), calorimetric
techniques [DSC (differential scanning calorimetry) and ITC (iso-
thermal titration calorimetry)] and FFTEM (freeze-fracture trans-
mission electron microscopy). Also, the action of the peptides on
bacteria of different origin in microbial assays was investigated.
Using FTIR and DSC, our results indicated a strong fluidization of
the lipid A acyl chains due to peptide binding, with a decrease
in the endothermic melting enthalpy change of the acyl chains
down to a complete disappearance in the 1:0.5 to 1:2 [LPS]:
[peptide] molar ratio range. Via ITC, it was deduced that the
binding is a clearly exothermic process which becomes saturated
at a 1:0.5 to 1:2 [LPS]:[peptide] molar ratio range. The results
obtained with SAXS indicated a drastic change of the aggregate
structures of LPS into a multilamellar stack, which was visualized
in electron micrographs as hundreds of lamellar layers. This can
be directly correlated with the inhibition of the LPS-induced
production of tumour necrosis factor α in human mononuclear
cells, but not with the action of the peptides on bacteria.
Key words: antimicrobial peptide, cytokine induction, Fourier-
transform infrared (FTIR), Limulus test, lipopolysaccharide
neutralization (LPS neutralization), small-angle X-ray scattering
(SAXS).
INTRODUCTION
Cell wall-bound molecules of bacteria such as LPS (lipopolysac-
charide) may be released into the environment by the attack of
the immune system or simply due to cell division, and may then
interact with serum or membrane proteins such as soluble or
membrane-bound LBP (LPS-binding protein) and CD14 [1–3].
In a following step, this interaction may then promote specific
receptors such as TLR4 (Toll-like receptor 4)/MD2, which even-
tually leads to cell activation [4,5]. At low and moderate concen-
trations of LPS the subsequent inflammation reaction is beneficial
for the host, but at higher LPS concentrations the cascade of mo-
lecular and cellular events may lead to endotoxic shock syn-
drome with high mortality, particularly in critical care units [6,7].
It is known that lipid A, the hydrophobic moiety anchoring LPS
into the outer membrane of Gram-negative bacteria, constitutes
the ‘endotoxic principle’ of LPS. Enterobacterial lipid A consists
of a diglucosamine backbone phosphorylated at positions 1 and
4′ to which mainly six acyl chains are linked at positions 2,3
and 2′,3′. Furthermore, in all LPS chemotypes to lipid A two
special monosaccharides, Kdo (2-keto-3-deoxyoctonate), are
linked, which are negatively charged due to their carboxylate
groups. Thus a necessary condition for LPS neutralization is the
presence of positive charges, which can be achieved by the use
of cationic peptides [8]. Previously, we have synthesized peptides
based on the LALF (Limulus-anti-LPS-factor) from the horseshoe
crab Limulus polyphemus [9]. These partial structures containing
the LPS-binding domain or parts of it were found to have high
endotoxin-binding and neutralizing activities, comparable with
that of the parent recombinant rLALF protein [also called ENP
(endotoxin-neutralizing protein)] [10], and to be non-toxic for
erythrocytes or cultured human monocytes [11].
Based on these peptides, we have synthesized a number of cyc-
lic peptides and have performed a detailed biophysical character-
ization of their interaction with mutant Ra LPS from Salmonella
Minnesota strain R60, which has well-defined chemical structure
and corresponds to the active unit in heterogeneous mixtures of
wild-type LPS [12]. In some cases also deep rough mutant Re
LPS (from Salmonella Minnesota strain R595) as well as the
‘endotoxic principle’ lipid A were used. Information was obtained
with regard to changes caused by peptide binding in the LPS/lipid
A aggregate structure, phase transition behaviour (temperature
Abbreviations used: cfu, colony-forming units; DSC, differential scanning calorimetry; FFTEM, freeze-fracture transmission electron microscopy;
Fmoc, fluoren-9-ylmethoxycarbonyl; FRET, fluorescence resonance energy transfer; FTIR, Fourier-transform infrared; ITC, isothermal titration calorimetry;
LPS, lipopolysaccharide; LALF, Limulus-anti-LPS factor; cLALF, cyclic LALF; LB, Luria–Bertani; LBP, LPS-binding protein; MBC, minimal bactericidal
concentration; MIC, minimal inhibitory concentration; MNC, mononuclear cells; NBD, 7-nitrobenz-2-oxa-1,3-diazole; PE, phosphatidylethanolamine; PMB,
polymyxin B; PS, phosphatidylserine; Rh, rhodamine; RP-HPLC, reversed-phase HPLC; SAXS, small-angle X-ray scattering; TFA, trifluoroacetic acid;
TLR4, Toll-like receptor 4; TNFα, tumour necrosis factor α.
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Figure 1 Amino acid sequences of the synthesized cyclic LALF peptides
The cyclation is performed between the two cysteine residues as indicated for cLALF20.
and enthalpy), mobilities of the acyl chains in the single phases,
the binding epitopes, in particular the negative charges in lipid A,
and the binding stoichiometry. Correlation of these results with
data on the cytokine-inhibiting capacity of the peptides and their
antimicrobial activity clearly established that the neutralizing
activity of the peptides was linked to their affinity for LPS
and to their ability to incorporate into target cell membranes.
These results allow an understanding of the mechanism of the
endotoxin–peptide interaction.
EXPERIMENTAL
Lipids
LPSs from rough mutant Re and Ra from Salmonella Minnesota
(strains R595 and R60 respectively) were extracted by the
chloroform/light petroleum method [13] from bacteria grown at
37 ◦C, purified, and freeze-dried. Free lipid A was isolated by
acetate buffer treatment of LPS R595. After isolation, the resulting
lipid A was purified and converted into its triethylamine salt.
Results of all the standard assays performed on the purified LPS
and lipid A (analysis of the amount of glucosamine and total and
organic phosphate, and the distribution of the fatty acid residues)
were in good agreement with the chemical properties expected
for LPS R595 and R60, whose molecular structure has already
been solved [14].
Preparation of endotoxin aggregates
LPS or lipid A was solubilized in the appropriate buffer (lipid
concentration 1–10 mM, depending on the applied technique),
extensively vortex-mixed, sonicated for 30 min in a water bath,
and subjected to several temperature cycles between 20 and 60 ◦C.
Finally, the lipid suspension was incubated at 4 ◦C for at least 12 h
before use.
Peptides
Peptides containing the described LPS-binding domain of LALF
[15] termed cLALF9, 12, 15, 16, 18 and 20 (where c is cyclic;
for structures, see Figure 1) were synthesized with an amidated
C-terminus by the solid-phase peptide synthesis technique on an
automatic peptide synthesizer (model 433 A; Applied Biosys-
tems) on the standard Fmoc (fluoren-9-ylmethoxycarbonyl)-
amide resin according to the FastMoc synthesis protocol of
the manufacturer. The N-terminal Fmoc group was removed
from the peptide resin and the peptide was deprotected and
cleaved with 90% (v/v) TFA (trifluoroacetic acid), 5% anisole,
2% thioanisole and 3% DTT (dithiothreitol) for 3 h at room
temperature (22 ◦C). After cleavage the suspension was filtered
and the soluble peptides were precipitated with ice-cold diethyl
ether followed by centrifugation and extensive washing with
diethyl ether. Peptides were purified by RP-HPLC (reversed-phase
HPLC) using an Aqua-C18 column (Phenomenex). Elution was
done by using a gradient of 0–70% acetonitrile in 0.1% TFA.
Cyclation via cysteine residues was achieved by incubating the
peptides in 10% (v/v) DMSO for 24 h at room temperature.
The peptides were then again purified by RP-HPLC to purities
above 95%. Purity was determined by MALDI–TOF-MS
(matrix-assisted laser-desorption–time-of-flight MS; Bruker). In
some cases, peptide cLALF22, corresponding to the complete
LPS-binding domain of LALF [16], was used. It differs from
cLALF20 by the additional amino acids HY between the GC and
the RI residues [third and fourth amino acid from the N-terminus
(Figure 1)].
FTIR (Fourier-transform infrared) spectroscopy
The IR spectroscopic measurements were performed on an IFS-
55 spectrometer (Bruker). Samples, dissolved in 20 mM Hepes
buffer (pH 7.0), were placed in a CaF2 cuvette with a 12.5 µm
Teflon spacer. Temperature scans were performed automatically
between 10 and 70 ◦C with a heating rate of 0.6 ◦C min−1. Every
3 ◦C, 50 interferograms were accumulated, apodized, Fourier-
transformed, and converted into absorbance spectra.
DSC (differential scanning calorimetry)
DSC measurements were performed with VP-DSC and MC-2
calorimeters (Microcal) at a heating and cooling rate of 1 ◦C min−1.
The DSC samples were prepared by dispersing a known amount
(∼3 mg/ml) in 10 mM PBS buffer at pH 7.4. The samples were
hydrated in the liquid crystalline phase by vortex-mixing. Prior to
the measurements the DSC samples were stored for a defined
time at 4 ◦C (see below). The measurements were performed
in the temperature interval from 5 to 95 ◦C. In the Figures only
the temperature ranges where phase transitions were observed are
shown. Five consecutive heating and cooling scans checked the
reproducibility of the DSC experiments of each sample [17].
The accuracy of the DSC experiments was +−0.1 ◦C for the
main phase transition temperatures and +−1 kJ/mol for the main
phase transition enthalpy. The DSC data were analysed using the
Origin software. The phase transition enthalpy was obtained by
integrating the area under the heat capacity curve [18].
ITC (isothermal titration calorimetry)
Microcalorimetric measurements of peptide binding to endo-
toxins were performed on an MCS isothermal titration calori-
meter (Microcal) at 37 ◦C as previously described [19]. Endotoxin
samples (0.05–0.15 mM), prepared as described above, were dis-
pensed into the microcalorimetric cell (volume 1.3 ml) and pep-
tide solutions in the concentration range 0.5–5 mM were filled into
the syringe compartment (volume 100 µl), each after thorough
degassing of the suspensions. After temperature equilibration, the
peptides were titrated in 3 µl portions every 5 min into the lipid-
containing cell under constant stirring, and the measured heat of
interaction after each injection measured by the ITC instrument
was plotted against time. As addition of the peptides into pure
buffer solution gave only negligible heat of dilution, the total heat
signal from each experiment was determined as the area under the
respective single peaks and plotted against the [peptide]:[lipid]
molar ratio. Since the instrument works in temperature equil-
ibrium at a constant ‘current feedback’ corresponding to a power
of approx. 74 µW, the occurrence of an exothermic reaction leads
to a lowering of this current, whereas an endothermic reaction
causes an increase. All titration curves were repeated at least
twice.
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X-ray diffraction
X-ray diffraction measurements were performed at the EMBL
(European Molecular Biology Laboratory) outstation at the
Hamburg synchrotron radiation facility HASYLAB using the
double-focusing monochromator–mirror camera X33 [20]. Dif-
fraction patterns in the range of the scattering vector 0.1< s<
4.5 nm−1 (s = 2sinθ /λ, where 2θ is the scattering angle and λ is
the wavelength = 0.15 nm) were recorded at 40 ◦C with exposure
times of 1 min using an image plate detector with online readout
(MAR345; MarResearch). The s-axis was calibrated with Ag-
Behenate, which has a periodicity of 58.4 nm. The diffraction
patterns were evaluated as described previously [21] assigning
the spacing ratios of the main scattering maxima to defined three-
dimensional structures. The lamellar and cubic structures are most
relevant here. They are characterized by the following features.
(i) Lamellar: the reflections are grouped in equidistant ratios, i.e.,
1, 1:2, 1:3, 1:4 etc. of the lamellar repeat distance dl. (ii) Cubic:
the different space groups of these non-lamellar three-dimensional
structures differ in the ratio of their spacings. The relation between
reciprocal spacing shkl = 1/dhkl and lattice constant a is
shkl = [(h2 + k2 + l2)/a]1/2
(hkl = Miller indices of the corresponding set of planes).
FFTEM (freeze-fracture transmission electron microscopy)
LPS and LPS/peptide samples were prepared as described above
with around 90% water content (3–5 mg/30 µl). For freeze-
fracturing, the samples, copper sandwich profiles, and instruments
for manipulation were incubated at room temperature or at 40 ◦C.
A small amount of the sample was sandwiched between two
copper profiles as used for the double-replica technique and
frozen by plunging the sandwiches immediately into liquified
propane cooled in liquid nitrogen. Fracturing and replication
were performed at −150 ◦C in a BAF 400T freeze-fracture
device (BAL-TEC) equipped with electron guns and a film sheet
thickness monitor. The replicas were placed on copper grids,
cleaned with a chloroform/methanol mixture, and examined in
an EM900 electron microscope (Zeiss).
FRET (fluorescence resonance energy transfer)
The FRET technique was used as a probe dilution assay [22]
to obtain information on the intercalation of the peptides in the
absence and presence of LPS into liposomes made from PS (phos-
phatidylserine). For the FRET experiments, liposomes were
double-labelled with NBD (7-nitrobenz-2-oxa-1,3-diazole)-PE
(phosphatidylethanolamine) and Rh (rhodamine)-PE in chlo-
roform [PS]:[NBD-PE]:[Rh-PE] at 100:1:1 molar ratios. The
solvent was evaporated under a stream of nitrogen, the lipids
resuspended in PBS, mixed thoroughly, and sonicated with a
Branson sonicator for 1 min (1 ml solution). Subsequently, the
preparation was temperature-cycled at least twice between 4 and
56 ◦C, each cycle followed by intense vortex-mixing for a few
minutes, and then stored at 4 ◦C for at least 12 h prior to measure-
ment. A preparation of 900 µl of the double-labelled liposomes
(10−5 M) at 37 ◦C was excited at 470 nm (λex of NBD-PE), and the
intensities of the emission light of the donor NBD-PE (531 nm)
and acceptor Rh-PE (593 nm) were measured simultaneously
on the fluorescence spectrometer SPEX F1T11 (SPEX Instru-
ments). The peptides cLALF (final concentration 1 µM) were
added to liposomes after 50 s, and LPS after 100 s (cLALF/LPS
1:1 molar ratio). Furthermore, co-incubated (LPS + cLALF)
samples were added after 50 s. Since FRET spectroscopy is used
here as a probe dilution assay, intercalation of molecules causes
an increase in the distance between donor and acceptor in the
liposomes and, thus, leads to a reduced energy transfer. This
again causes an increase in the donor and decrease in the acceptor
intensities. For a qualitative analysis of experiments, the quotient
of the intensities of the donor dye and the acceptor dye are plotted
against time (denoted in the following as the FRET signal). The
results shown are representative of three independent experiments.
Stimulation of human MNCs (mononuclear cells) by LPS
MNCs were isolated from heparinized blood of healthy human
donors as described previously [23]. The cells were resuspended
in medium (RPMI 1640) and their number was equilibrated at
5 × 106 cells/ml. For stimulation, 200 µl of MNC (1 × 106 cells)
was transferred into each well of a 96-well culture plate. LPS and
peptide/LPS mixtures were incubated for 30 min at 37 ◦C,
and added to the cultures at 20 µl per well. The cultures were in-
cubated for 4 h at 37 ◦C under 5% CO2. Supernatants were
collected after centrifugation of the culture plates for 10 min at
400 g and stored at −20 ◦C until determination of TNFα (tumour
necrosis factor α) content. Immunological determination of TNFα
was carried out in a Sandwich ELISA using a monoclonal anti-
body against TNF (clone 6b from Intex AG) and was described
earlier in detail [23].
Assays for cytotoxicity
Cytotoxicity of the peptides was determined against HeLa cells in
medium by an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide] assay as described previously [24].
Assay for haemolytic activity
Haemolytic activity of the peptides against human erythrocytes
was determined as described previously [24]. Briefly, peptides
were incubated with a freshly prepared erythrocyte suspension
from human blood (5% of normal haematocrit) in 10 mM PBS
(pH 7.2), for 30 min at 37 ◦C. Released Hb was determined
photometrically at 412 nm.
Assays for antibacterial activities
The antibacterial activity of the peptides was determined by
microdilution susceptibility assays performed (i) in standard
Mu¨ller–Hinton broth or (ii) in 20 mM Hepes buffer (pH 7.0)
supplemented with 10% LB (Luria–Bertani) broth.
Assay in Mu¨ller–Hinton broth
Susceptibility testing was performed following the recommend-
ations of the CLSI [Clinical Standards Institute; formerly
NCCLS (National Committee for Clinical Laboratory Standards)]
(Standards, 2000) [25]. Peptides [2 mg/ml in 4 mM Hepes
(pH 7.2)] were two-fold diluted in Mu¨ller–Hinton broth (pH 7.3)
(Difco Laboratories) in 96-well microtitre plates (TPP) to obtain
concentrations from 512 to 0.25 µg/ml in a volume of 100 µl.
Bacteria were grown on Mu¨ller–Hinton agar plates (bioMe´rieux)
for 1–3 days depending on the growth rate of the bacteria,
suspended in 2 ml of 0.9% saline and adjusted to 108 cfu (colony-
forming units)/ml. The bacterial suspension was diluted 100-fold
in Mu¨ller–Hinton broth, and 0.1 ml of this new dilution (105 cfu)
was added to the peptide dilutions. The microtitre plates were
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incubated at 37 ◦C for 24 h. The MIC (minimal inhibitory concen-
tration) of each peptide against a given bacterial strain was re-
garded as the minimal concentration of the peptide that prevents
the growth of that organism 24 h after inoculation. The bacteri-
cidal effect of the peptides was determined, after 24 h incubation
at 37 ◦C, by plating 10 µl of the content of non-cloudy wells on
to Mu¨ller–Hinton agar plates. Plates were incubated at 37 ◦C for
1–5 days, and a viable count was performed. The MBC (minimal
bactericidal concentration) of each peptide for a given bacterial
strain was regarded as the minimal concentration of the peptide
that kills 99.9% of the cfu present in the final inoculum.
Assays in LB medium/buffer
Peptides (dissolved in 20 mM Hepes, pH 7.0) were 2-fold
diluted in the same buffer in 96-well microtitre plates (Greiner).
Subsequently, a suspension of exponential-phase bacteria in LB
was added (10 µl, containing 104 cfu) to the peptide solution
(90 µl). The plates were incubated overnight in a wet chamber at
37 ◦C under constant shaking and bacterial growth was monitored
by measuring the absorbance at 620 nm in a microtitre plate reader
(Rainbow; Tecan). The MIC was defined as the lowest peptide
concentration at which no bacterial growth was measurable.
Portions of each well (10 µl) were diluted with 90 µl of Hepes
buffer, plated out in duplicate on to LB-agar plates, incubated
overnight at 37 ◦C, and bacterial colonies were counted. The
MBC was defined as the peptide concentration at which no colony
growth was observed. Experiments were performed at least twice
in duplicates.
RESULTS
Various physical techniques were applied to characterize the
interaction of LPS Ra, in some cases also of LPS Re and lipid A
as endotoxic principle, with the peptides.
Gel-to-liquid crystalline phase transition behaviour
The influence of the peptides on the gel-to-liquid crystalline
β ↔α phase behaviour of the acyl chains of LPS Ra, as studied
by DSC, showed for all peptides strong interaction with the
LPS aggregates (Figure 2). For all peptides, the endothermic
melting enthalpy of the hydrocarbon chains of LPS decreased
with increasing peptide concentration and vanished at equimolar
ratios. The peptides cLALF15 and 20 acted strongest, for which
the endotherm disappears at an [LPS]:[peptide] 2:1 molar ratio.
This became evident more clearly when the enthalpy change H
of the acyl chain melting transition was plotted against the [LPS
Ra]:[peptide] molar ratio (Figure 3). From these results, it can
be concluded that, besides the electrostatic attraction between the
positive charges of the peptide and the negative charges of LPS,
a hydrophobic interaction also takes place, leading to a complete
abolishment of the chain melting. This chain melting-abolishing
effect can be interpreted in two ways, as fluidization of the hydro-
carbon chains at low temperatures or as maintaining of the gel
phase up to high temperatures. To differentiate between these
possibilities, FTIR was applied by monitoring the peak position
of the symmetric stretching vibration of the hydrocarbon chains
νs (CH2) against temperature. This is plotted in Figure 4 for the
interaction of LPS Ra with cLALF9, 15, 18 and 20. As it is known
that the peak position of νs (CH2) lies around 2850 cm−1 in the
gel and around 2852.5–2853 cm−1 in the liquid crystalline phases
[26], it can be deduced from Figure 4 that the action of the peptides
led to a fluidization of the acyl chains in the gel phase, connected
Figure 2 DSC heating-scans of LPS R60 in the presence of different
concentrations of peptides cLALF9–20
The specific excess heat capacity, Cp diff , of the calorimetric sample cell as compared with
the reference cell is plotted against temperature. The peak positions directed upwards are
characteristic for endothermic chain melting processes.
Figure 3 Calorimetrically determined enthalpy change, Hc, against
[LPS]:[peptide] molar ratio from DSC scans of Figure 2
with a strong reduction of the phase-transition temperature Tc. In
particular at 37 ◦C, a dramatic increase in the wavenumber values
to more than 2853 cm−1 took place. Nevertheless, the change of
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Figure 4 Gel-to-liquid crystalline phase behaviour of the hydrocarbon chains in the lipid A moiety of LPS in the absence and presence of cLALF9, 15, 18
and 20 in FTIR experiments
Plotted is the peak position of the symmetric stretching vibration of the methylene groups against temperature. The gel phase corresponds to wavenumber values around 2850 cm−1 and the liquid
crystalline phase corresponds to values around 2852.5–2853.0 cm−1.
the wavenumbers over a broad temperature range (10–40 ◦C) for
the LPS/peptide mixtures at 1:0.5 and 1:1 molar ratio is a hint that
in the DSC scans this transition cannot be observed enthalpically.
Binding experiments
ITC is the method of choice to determine the enthalpy change
caused by the peptide–LPS binding and its stoichiometry. For
this, 0.05 mM LPS Ra dispersions were titrated with 2 mM pep-
tide solutions. One original titration is shown in Figure 5(A)
for LPS Ra and cLALF20 showing an exothermic reaction (de-
crease of feedback power to compensate for the temperature
increase in the sample cell). A saturation is observed after
the tenth injection (after approx. 2500 s). When plotting the
integrated areas of the enthalpy curves (enthalpy change Hc)
against [LPS]:[peptide] molar ratios (Figure 5B), it can be
deduced that (i) for all peptides the negative enthalpy change
Hc corresponds to exothermic reactions, and (ii) the titrations
indicate a two-step process. Thus, for cLALF15, minima in the
curve were observed at [LPS]:[peptide] = 0.3 and 1.6 respectively.
Furthermore, binding saturation took place at the highest molar
ratio for cLALF9 ([LPS]:[peptide] = 2) and was lowest for
cLALF20 ([LPS]:[peptide]<1). The saturation values for the
other peptides were intermediate between these two.
Ultrastructural analysis
It has been shown that non-lamellar aggregate structures for
LPS (in particular the lipid A part of LPS) are essential for the
expression of biological activity [27]. We thus applied synchrotron
radiation small-angle X-ray diffraction to determine the aggregate
structure of LPS in the presence of the peptides. For the latter, we
used deep rough mutant LPS Re with a short core oligosaccharide
rather than LPS Ra with the complete core oligosaccharide [28],
since the spectra of the former are more readily resolvable and
interpretable [29,30]. The diffraction patterns for pure LPS Re
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Figure 5 Isothermal calorimetric titration of 0.05 mM LPS Ra with 2 mM cLALF peptides (30× 3 µl every 5 min)
(A) Original titration of LPS with cLALF20 (raw data). (B) Integrated peak areas of the single titrations according to (A) against [peptide]:[LPS] molar ratios for cLALF9, 15, 18 and 20.
were indicative of the existence of a mixed unilamellar/cubic
structure, as described earlier [29] (results not shown). In the pre-
sence of the peptides cLALF18 and 20, the diffraction patterns
in the temperature range 5–60 ◦C were characteristic for the ex-
istence of multilamellar structures, deduced from the occurrence
of reflections at equidistant ratios (Figure 6A). For the LPS–
cLALF18 complex, a closer look at the patterns at 40 ◦C (Fig-
ure 6B) showed a main periodicity at 6.62 nm and three further
reflections corresponding to the higher orders, and some smaller
peaks. These were more readily expressed for the LPS–cLALF20
complex, showing a second lamellar periodicity at 5.32 nm and
its second order at 2.64 nm (Figure 6B, bottom).
Regarding the periodicities, it has been shown for LPS Re that
these values lie in the range 5.90–6.40 nm in cases in which this
LPS adopts a multilamellar structure (in the presence of Mg2+ or
at low water content, [29]). Therefore the addition of cLALF18
apparently leads to an increase in lamellar stacking periodicity,
whereas that of cLALF20 does not, or is even decreased reflecting
the lower value of the periodicity.
Also, the aggregate structures of free lipid A (as ‘endotoxic
principle’) in the presence of cLALF18 and 20 were elucidated
(results not shown). Similar to the case of LPS Re, the reflections at
equidistant ratios indicated multilamellar structures. The values of
the periodicities (6.49 nm), however, were very high, considering
the fact that the values for pure lipid A are approx. 4.9–5.3 nm
[31]. Thus, in this case a strong increase of the water layer between
neighbouring bilayers due to peptide binding took place (swelling
of the interlamellar repeat).
For the system LPS Re–cLALF18 (2.5:1 molar ratio as in the X-
ray diffraction experiments), freeze-fracture electron microscopy
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Figure 6 Synchrotron radiation small-angle X-ray diffraction patterns of LPS/peptide mixtures ([LPS]:[cLALF]= 2.5:1 molar ratio)
The scattering vector s = 1/d = 2 sinθ /λ (where d is the spacing ratio, θ the scattering angle and λ the wavelength = 0.15 nm) is plotted against the logarithm of the scattering intensity, log I,
(A) at different temperatures and (B) at 40◦C, both for cLALF18 and 20.
was used. Micrographs are displayed in Figures 7(A)–7(C). For
pure LPS, vesicle-like structures are found in the size range
100–200 nm (Figure 7A). The structures, however, often are
not closed and form something like ‘open eggshells’. When the
peptide was added to the LPS, the suspension became turbid
with subsequent precipitation. The supernatant (Figure 7B) as
well as the precipitate (Figure 7C) were investigated. It can be
clearly seen that in the supernatant very large vesicle-like struc-
tures and multilamellar stacks are observed apparently due to the
formation of fused ‘eggshells’, with diameters of up to 500 nm.
For the precipitate, the morphology completely changes with the
occurrence of giant stacks. These stacks corresponded to
the multilamellar structures found in the X-ray experiments, with
distances between neighbouring stacks in the range 6.3–7.5 nm.
Figure 7(C) shows also that in cross-fractured areas stacks with
more than 100 single bilayer lamellae can be found.
Intercalation into phospholipid liposomes
A possible intercalation of the peptides or peptide/LPS mixtures
into phospholipid membranes were analysed by FRET. As shown
in Figure 8 for cLALF9 and cLALF18, the peptides alone (added
at t = 50 s) were able to intercalate into PS liposomes (increase
in FRET signal). When LPS was added subsequently at t = 100 s,
there was an additional incorporation, in contrast with added
LPS in the absence of the peptide, for which no incorporation
was observed (results not shown; see [22]). This means that the
peptides acted as a kind of transport molecule similar to that
observed for LBP [22].
Finally, when peptides and LPS (peptide/LPS) were incubated
before addition to the liposomes, the results indicate a reduced,
but still existing membrane incorporation.
Similar results were obtained for all other peptides investigated
(results not shown). In some experiments, instead of PS, phos-
pholipids corresponding to the composition of the macrophage
membrane (PLMφ) were used. The results were qualitatively the
same as with pure PS liposomes, only the observed signal inten-
sities were lower (results not shown).
Inhibition of LPS-induced stimulation of human MNCs
We tested the ability of the peptides to inhibit cell stimulation
by LPS Ra from Salmonella Minnesota strain R60. Cells were
stimulated by LPS alone or pre-incubated with various amounts
of peptide (Figure 9). All peptides interacted with LPS, as reflected
by a reduction in cell activation. Peptide cLALF12 was able to
completely block LPS-induced cell activation (1 ng/ml LPS) at
1 µg/ml. PMB (polymyxin B), the gold standard for cationic LPS-
neutralizing peptides, exhibited the same activity at a 10-fold
lower concentration.
Cytotoxicity and haemolytic activity
The potential harmful effects of the peptides to human cells were
estimated by assessing their cytotoxicity against HeLa cells and
their potency to lyse human erythrocytes. At a concentration of
100 µg/ml none of the peptides were cytotoxic and the haemolytic
activity was 15% or below (Table 1).
Antibacterial activity
The antibacterial activity of the peptides was determined first
against the LPS-mutant strains Salmonella Minnesota R595 and
R60 (used for the preparation of the LPS with defined structures
used in the experiments described above) grown in LB, a low
ionic strength medium that bolsters peptide antimicrobial activity.
These experiments suggested that none of the new peptides
outperformed the parent peptide cLALF22 (Table 1), but because
of the low MIC values obtained under these conditions and with
these sensitive LPS mutant strains, we performed additional and
more stringent experiments. To this end, we tested the anti-
bacterial activity in Mu¨ller–Hinton broth, which is rich in bivalent
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Figure 7 Freeze-fracture electron micrographs of LPS from Salmonella
MinnesotaRe alone (A) and in the presence of cLALF18 ([LPS]:[cLALF]= 3:1)
(B) supernatant and (C) precipitation
cations, and using a smooth-type Escherichia coli strain and a
clinical isolate of Pseudomonas aeruginosa, a bacterium with
an outer membrane and LPS markedly stabilized by bivalent
cations. Under these more stringent conditions, the parent peptide
cLALF22 outperformed all the derivatives. This was particularly
clear with Ps. aeruginosa, highlighting the lack of an effective
displacement of bivalent cations from outer membrane and LPS
targets by the other peptides (Table 1). It should be mentioned,
Figure 8 Intercalation of peptide/LPS samples andHepes buffer control into
target cell liposomes made from PS in FRET spectroscopic measurements
Presented is the FRET signal ID/IA against time for cLALF9 (upper panel) and cLALF18 (lower
panel). The samples were added subsequently at 50 and 100 s to the liposomes.
however, that some of the variants exhibited activity against
Salmonella aureus. With respect to the most resistant bacterium,
i.e. Ps. aeruginosa, cLALF9 was the peptide with highest activity
beside cLALF22.
DISCUSSION
The development of suitable antimicrobial peptides for a therapy
for septic shock and also to fight against local infections is still
a challenge in human health care, considering the increase in in-
fectious diseases worldwide and problems such as the emergence
of resistances [32]. For these purposes, the development of
drugs based on natural endotoxin-binding structures seems a
promising approach. This approach comprises, for example, the
use of lactoferrin-based [24] and of LALF-based peptides [9]. For
synthetic peptides based on the sequence of endotoxin-binding
proteins like LALF, it has been shown previously, that some are
in principle suitable for application in anti-sepsis research, in
particular as they have a sufficiently long half-life in serum [33].
Previously, we have published biophysical data on the interaction
of some synthetic cyclic peptides with LPS Re, and reported
that certain physicochemical parameters of the LPS Re–peptide
interaction correlate with the ability to neutralize LPS [34]. On
the basis of these findings, we have constructed several new cyclic
c© The Authors Journal compilation c© 2007 Biochemical Society
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Figure 9 Concentration-dependent inhibition of the biological activity of
LPS Ra from Salmonella Minnesota strain R60 by synthetic peptides
Peptides were incubated with 1 ng/ml LPS at the indicated peptide concentrations and used
to activate human MNCs. As a marker of LPS-induced cell activation, the production of the
cytokine TNFα was determined by ELISA. Activation of the cells by LPS alone represents 100 %.
PMB served as a control. Results presented are the means for two independent cell stimulations
from two different preparations and each stimulation performed in duplicate.
peptides (cLALF 9, 12, 15, 16, 18 and 20). These peptides were
designed on the basis of obtaining the hydrophobic cluster at
the C-terminus and shortening the peptides stepwise from the
N-terminus (Figure 1). We have performed a comprehensive
biophysical and biological study of their interaction with the well-
characterized endotoxins LPS Re and LPS Ra from Salmonella
Minnesota strains R595 and R60. Except for the ultrastructural
studies in which LPS Re was used, the latter was studied because
it has been shown that the endotoxically active unit in natural
smooth-form LPS corresponds to an LPS with a complete core
oligosaccharide [12].
Our results indicate a strong interaction of the peptides both
with bacteria and with isolated LPS. The antibacterial activity
of the peptides was clearly more marked on LPS-deficient
Salmonella mutants in low ionic strength broth than on wild-
type clinical isolates in the bivalent-cation rich Mu¨ller–Hinton
broth. In fact, under the more stringent conditions, only the parent
peptide exhibited activity on Ps. aeruginosa (Table 1). It should
be noted, however, that this bacterium is notoriously refractory to
bactericidal peptides under these conditions, and this highlights
the activity of cLALF22. On the other hand, the peptides were
not cytotoxic and were only slightly haemolytic (Table 1). In a
similar way, they were able to inhibit the LPS-induced cytokine
production of human MNCs (Figure 9). Very interesting is the
dependence of the antibacterial action on the presence of bivalent
cations (Mu¨ller–Hinton broth). The latter are known to stabilize
bacterial outer membranes as well as isolated LPS aggregates
[34]. Therefore the action of those peptides that essentially attack
the LPS layer of the outer membrane is impeded, which explains
the reduction in the MIC/MBC values (Table 1).
The binding of the peptides with LPS shows the following
features, which may be relevant for an understanding of the
binding to isolated LPS as well as to LPS as a constituent of
the outer bacterial membrane.
The binding led to a strong fluidization of the hydrocarbon
chains of LPS (Figure 4), with a disappearance of the phase-
transition enthalpy (Figures 2 and 3) similar to the observations
made for the well-known decapeptide PMB [19]. Concomitantly,
a change in the aggregate structures of LPS and lipid A, being
unilamellar or mixed unilamellar/inverted cubic in pure form,
into multilamellar stacks (Figure 6 and results not shown) was
observed, also like PMB. This process is strongly exothermic
(Figures 5A and 5B) due to the electrostatic attraction between
the negative charges of LPS/lipid A and the positive charges of the
peptides (in particular, amino acids arginine and lysine; Figure 1).
The enthalpic values (maximum values more than 40 kJ/mol, see
Figure 5B) also compare well with those from the interaction of
PMB and the nonapeptide PMBN (PMB nonapeptide) with LPS
[35].
The electron micrographs (Figure 7) give a clear impression
of the underlying morphology, with nearly spherical vesicle-like
structures (‘open eggshells’, Figure 7A) for pure LPS, and very
large ‘giant’ liposomal structures in the supernatant (Figure 7B),
apparently due to fusions of the single ‘eggshells’. In the preci-
pitate, huge stacks were found (Figure 7C) corresponding to the
multilamellae deduced from SAXS (small-angle X-ray scattering)
experiments. As already proposed in a preceding paper, the degree
of multilamellarization may be a direct measure of the ability of
a given peptide to inhibit the LPS-induced cytokine production in
MNCs [24]. According to theoretical considerations by Bouwstra
et al. [36], from the shapes of the reflections at equidistant ratios,
statements about the number of lamellae and size distributions
of particles should be possible. Unfortunately, this is apparently
valid only for relatively simple situations for pure phospholipids.
Table 1 Antibacterial, cytotoxic and haemolytic activities of cLALF peptides
Antibacterial activity is given as MIC (MBC) in µg/ml and was determined by microdilution assays in (i) 10 % LB/90 % buffer and (ii) Mu¨ller–Hinton broth (see the Experimental section). Cytotoxicity
against HeLa cells and lysis of human erythrocytes was determined for 100 µg/ml peptide and was calculated relative to an untreated control.
Salmonella Salmonella Pseudomonas HeLa cells Human erythrocytes
Peptide Minnesota R595* Minnesota R60* E. coli ATCC 25922† aeruginosa† Salmonella aureus† (% cytotoxicity) (% Hb release)
cLALF9 4 (8) 8 (16) 64 (64) 256 (256) 128 (256) 0 9
cLALF12 4 (16) 8 (32) 64 (128) >256 (>256) 64 (128) 0 11
cLALF15 4 (32) 8 (32) 32 (32) >256 (>256) 64 (64) 0 14
cLALF16 4 (16) 16 (32) 64 (64) >256 (>256) 128 (128) 0 15
cLALF18 4 (16) 8 (32) 256 (256) >256 (>256) 256 (256) 0 11
cLALF20 8 (16) 16 (64) 64 (128) >256 (>256) >256 (>256) 0 6
cLALF22 2 (4) 8 (16) 32 (32) 32 (64) n.d. 0 19
* 10 % LB/90 % buffer.
† Mu¨ller–Hinton broth.
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For LPS, in cases in which multilamellar aggregates are formed (at
low water content and/or high Mg2+ concentrations [29,30]), we
did not succeed in obtaining this information (J. Andra¨, J. Howe
and K. Brandenburg, unpublished work). Furthermore, due to
the fact that for LPS/peptide mixtures we did not see spherical
liposomes but rather relatively different forms in the supernatant
and completely different morphologies in the precipitate, the data
analysis of Bouwstra et al. [36] is not applicable. Therefore SAXS
measurements alone are not sufficient for a complete analysis, and
the number of lamellae must be estimated by a different technique,
i.e. by analysing the FFTEM pictures. For cLALF18, Figure 7(C)
is indicative that stacks with very high numbers of lamellae are
formed, and these can be enumerated (most of them are >100). It
is tempting to assume that this is relevant for the interpretation of
biological data, since the interaction of LPS with binding proteins
such as CD14 and LBP is reduced for stacks with a high number of
lamellae as compared with the unilamellar system in the absence
of the peptide. Finding a satisfactory explanation for this will be
a task for the future.
We have found here a significant increase of the aggregate
sizes of LPS (Figure 7C) concomitant with a multilamellarization
(Figure 6), in contrast with the findings of Rosenfeld et al. [37],
who report that peptides such as human LL-37 and magainin
would lead to a dissociation of the LPS aggregates thus prevent-
ing them from reacting with LBP or cellular receptors. These
authors, however, use more indirect techniques such as flow cyto-
metry with FITC-labelled LPS, which does not represent a
direct technique as shown here with the FFTEM method, and
furthermore, they have used chemically ill-defined smooth-form
LPS which usually consists of a mixture of fractions differing in
the length of the sugar chains and the acylation of the lipid A part
[12].
It must be emphasized that, except for uncharacterized wild-
type LPS [S-LPS (smooth LPS)] in older papers [38], no electron
micrographs of chemically characterized endotoxins have ever
been published. For lipid A, we have previously characterized
the non-lamellar structures using SAXS and FFTEM [39]. A
combination of SAXS and cryo-TEM (cryo-transmission electron
microscopy) was applied to analyse the interaction of granulysin-
derived peptides with endotoxins, in particular with LPS Ra from
Salmonella Minnesota [40]. The authors found, for pure LPS
Ra, fibrillary structures with cylindrical forms with a diameter
of the fibrils of 12 nm, whereas in the presence of a granulysin-
derived peptide, regularly stacked ribbons emerged, which would
correspond to the multilamellar stacks of LPS Re as seen here.
It is important to note that the results of the combined electron
microscopy and SAXS measurements presented here allow the
unequivocal elucidation of the underlying aggregate structures,
which should be of uttermost use in the interpretation of the
inhibition activity of the peptides.
For an understanding of the interaction mechanism, the FRET
data (Figure 8), which exhibit an intercalation of the peptides into
liposomal membranes, are important. This may be of relevance
for their antibacterial activity (Table 1) as well for the inhibition of
the LPS-induced cytokine expression (Figure 9): for the former,
because the bacterial membranes may thus be heavily disturbed
in their function, and for the latter, since the uptake of the peptide
into the membranes of MNCs can be assumed to be of relevance
for their ability to secrete cytokines. There is considerable
evidence that the cell activation by LPS starts via a membrane step,
induced by binding proteins such as LBP and CD14 [2,41–44].
The detailed mechanisms, however, are not completely resolved.
It has been proposed that LBP accelerates the binding of LPS
to CD14, and/or that LBP leads to a disintegration, possibly
monomerization, of LPS aggregates [2,45], which would imply
that the presence of monomers or small aggregates of endotoxin
are necessary for endotoxic activity, in accordance with the
findings of Takayama et al. [46]. In contrast, Mueller et al.
[47,48] showed that aggregates are the biologically active units
of endotoxins. We have found that the binding of LBP to LPS
leads to a multilamellarization of LPS, which is indicative of
an increase rather than a decrease of aggregate sizes as found
here for peptide binding (J. Andra¨, J. Howe and K. Brandenburg,
unpublished work). Independently of this question, it can be
stated that LPS incorporated into target cell membranes represents
a strong disturbance of the membrane architecture due to the
conical geometry (shape) of its lipid A moiety, which triggers cell
activation by leading to a conformational change of membrane
proteins responsible for cell signalling such as TLR4 [5,49],
MaxiK [50], or a complete receptor cluster [51,52]. Since the
peptides also incorporate into the membrane, they may be able to
change the conical shape of LPS by inducing a lamellar geometry,
as was seen in the X-ray diffraction experiments for LPS Re
(Figure 6) and lipid A (results not shown).
Conclusions
The ability of the peptides to act antimicrobially and to inhibit
the LPS-induced cytokine secretion without exhibiting cytotoxi-
city and haemolysis makes them or their derivatives potential
candidates in sepsis therapy. In the present paper, the biophys-
ical prerequisites for effective endotoxin neutralization have been
described: an exothermic reaction between LPS and peptides
leading to a fluidization of the lipid A acyl chains with
concomitant disappearance of the gel-to-liquid crystalline phase
transition, a multilamellarization of the aggregate structure of LPS
with a very high number of bilayer stacks, and an incorporation
of the peptides into target phospholipids as a model of immune
cell membranes.
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